However, consistent with previous studies, impeding IFN-γ function did not affect primary 4T1 tumor outgrowth [84,85], and neutralizing IFN-γ did not affect GEM’s ability to constrain 4T1 tumor outgrowth (Figure 5), indicating that the anti-tumoral effects of GEM are not dependent of IFN-γ. The gene discussed is IFNG; the disease is neoplasm.